You are here: All Products  > Everest Acquires China Rights to Kidney Disease Treatment in $121 Million Pact

Everest Acquires China Rights to Kidney Disease Treatment in $121 Million Pact

Price: $5.00
Available


Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products